Meta10-GPC3 CAR-T cells

GPC3-targeted CAR-T cells · Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meta10-GPC3 CAR-T cells, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma [EARLY_Phase 1]

See pricing